Addiction treatment legislation

House Commerce Committee Chairman Bliley (R-Va.) introduces "The Drug Addiction Treatment Act" July 30. The bill, a companion piece to Senate legislation (S 324) introduced in January by Sens. Hatch (R-Utah) and Levin (D-Mich.), would allow Schedule IV and V controlled substances for the treatment of addiction to be administered in a physician's office, allowing for wider distribution and application of drugs like Reckitt & Coleman's buprenorphine, which is pending approval at FDA (1"The Pink Sheet" March 15, p. 19)

House Commerce Committee Chairman Bliley (R-Va.) introduces "The Drug Addiction Treatment Act" July 30. The bill, a companion piece to Senate legislation (S 324) introduced in January by Sens. Hatch (R-Utah) and Levin (D-Mich.), would allow Schedule IV and V controlled substances for the treatment of addiction to be administered in a physician's office, allowing for wider distribution and application of drugs like Reckitt & Coleman's buprenorphine, which is pending approval at FDA (¹ (Also see "Reckitt Subutex Combo NDA Nears Filing; Legislation Could Widen Availability" - Pink Sheet, 15 Mar, 1999.)).